病毒性肝炎诱导的肝细胞癌中的免疫路径
Lingdong Xu1,2, Yifan Xu3, Fei Zhang3,4
1Laboratory Animal Center, Zhejiang University, Hangzhou 310058, China. xulingdong@zju.edu.cn.
肝炎病毒是肝癌 (肝细胞癌,HCC) 的主要原因. 了解病毒的作用和免疫反应是制定HCC有效预防和治疗策略的关键.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 在瘤学瘤学.
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,病毒性肝炎是主要的驱动因素.
- 乙型肝炎 (HBV),C型肝炎 (HCV) 和越来越多的E型肝炎 (HEV) 病毒通过慢性炎症,肝硬化和遗传突变与HCC的发展有关.
- 甲型肝炎 (HAV) 和D型肝炎 (HDV) 病毒也在HCC的发病和风险中起作用.
研究的目的:
- 提供关于肝炎病毒及其与HCC相关性的全面概述.
- 审查最近关于病毒病原,异常肝免疫反应和HCC发展的研究.
- 突出早期检测,干预和疫苗接种对于预防HCC的重要性.
主要方法:
- 临床病理学研究的文献综述和最近的研究进展.
- 分析不同肝炎病毒对HCC的贡献机制.
- 检查病毒蛋白 (例如HBx,HCV核心) 和宿主免疫反应的作用.
主要成果:
- 慢性HBV和HCV感染是HCC最常见的病毒前体.
- 特定的病毒突变 (HBV X蛋白) 和蛋白表达 (HCV核心) 与HCC发病率和瘤发生有关.
- 新出现的证据将慢性HEV感染,特别是免疫功能低下个体,与增加的HCC风险联系起来.
结论:
- 肝炎病毒是HCC发育中的关键病因因子.
- 对病毒与宿主相互作用和免疫反应的进一步研究对于新的治疗策略至关重要.
- 疫苗接种和及时对肝炎病毒进行干预对于减少全球肝癌负担至关重要.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
相关概念视频
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Mechanisms of Retrovirus-induced Cancers
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Cell-mediated Immune Responses
